Literature DB >> 21514553

A customized standard of large size for gestational age to predict intrapartum morbidity.

Jacob C Larkin1, Paul D Speer, Hyagriv N Simhan.   

Abstract

OBJECTIVE: The purpose of this study was to determine whether a customized standard of large-for-gestational age (LGA) identifies pregnancies with increased perinatal risk. STUDY
DESIGN: We evaluated 7510 estimates of fetal weight to generate a fetal growth curve. Next, we analyzed the gestational age at delivery, physiologic and pathological variables from 5072 pregnancies to predict birthweight, and calculated a customized ideal birthweight and cutoff for LGA. In a separate analysis of 32,271 pregnancies, rates of macrosomia-related adverse outcomes were compared in pregnancies that had been identified as LGA by a customized standard (LGA(cust)) and those pregnancies that had been identified as LGA or macrosomic by conventional standards.
RESULTS: LGA(cust) pregnancies carried increased risk of shoulder dystocia, third- or fourth-degree laceration, and cephalopelvic disproportion. LGA(cust) pregnancies that did not meet conventional criteria for LGA/macrosomia were at increased risk of all measured outcomes.
CONCLUSION: A customized standard of LGA identifies a previously unrecognized population that is at increased risk of perinatal morbidity.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21514553     DOI: 10.1016/j.ajog.2011.02.068

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

1.  Customized versus population approach for evaluation of fetal overgrowth.

Authors:  Maged M Costantine; Lisa Mele; Mark B Landon; Catherine Y Spong; Susan M Ramin; Brian Casey; Ronald J Wapner; Michael W Varner; Dwight J Rouse; John M Thorp; Anthony Sciscione; Patrick Catalano; Steve N Caritis; Yoram Sorokin; Alan M Peaceman; Jorge E Tolosa; Garland D Anderson
Journal:  Am J Perinatol       Date:  2012-11-12       Impact factor: 1.862

2.  Risk of adverse outcomes among infants of immigrant women according to birth-weight curves tailored to maternal world region of origin.

Authors:  Marcelo L Urquia; Howard Berger; Joel G Ray
Journal:  CMAJ       Date:  2014-11-10       Impact factor: 8.262

3.  Customized large-for-gestational-age birthweight at term and the association with adverse perinatal outcomes.

Authors:  Lindsey A Sjaarda; Paul S Albert; Sunni L Mumford; Stefanie N Hinkle; Pauline Mendola; S Katherine Laughon
Journal:  Am J Obstet Gynecol       Date:  2013-09-10       Impact factor: 8.661

4.  Combined Influence of Gestational Weight Gain and Estimated Fetal Weight on Risk Assessment for Small- or Large-for-Gestational-Age Birth Weight: A Prospective Cohort Study.

Authors:  Sarah J Pugh; Stefanie N Hinkle; Sungduk Kim; Paul S Albert; Roger Newman; William A Grobman; Deborah A Wing; Katherine L Grantz
Journal:  J Ultrasound Med       Date:  2017-09-29       Impact factor: 2.153

5.  Caveats in the monitoring of fetal growth using ultrasound estimated fetal weight.

Authors:  Nicholas John Dudley; Helen Varley
Journal:  Ultrasound       Date:  2020-09-11

6.  Variation in the maternal corticotrophin releasing hormone-binding protein (CRH-BP) gene and birth weight in Blacks, Hispanics and Whites.

Authors:  Pathik D Wadhwa; Hyagriv N Simhan; Sonja Entringer; Claudia Buss; Roger Smith; Calvin J Hobel; Naveed Farhana; Lawrence Shimmin; James E Hixson; Charles F Sing
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

7.  A wider pelvis does not increase locomotor cost in humans, with implications for the evolution of childbirth.

Authors:  Anna G Warrener; Kristi L Lewton; Herman Pontzer; Daniel E Lieberman
Journal:  PLoS One       Date:  2015-03-11       Impact factor: 3.240

Review 8.  Fetal Growth Acceleration-Current Approach to the Big Baby Issue.

Authors:  Jan Modzelewski; Anna Kajdy; Katarzyna Muzyka-Placzyńska; Dorota Sys; Michał Rabijewski
Journal:  Medicina (Kaunas)       Date:  2021-03-02       Impact factor: 2.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.